Login

Dr. Ian Walters, CEO, Portage Biotech Inc 00:00:00

Share On Facebook Share On Twitter

Portage’s Pipeline of Assets and What Makes Them Unique in the Immuno-Oncology Space

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Henderson Land Honored in Singapore with Second 'Developer of the Year' Award|Mr Yu Ching Yan Johnny,Advisor to Chairman,Henderson Land Development Co. Ltd.
00:10:00
Boston Hurries on an Extreme | Ed Meyercord, President and CEO, Aerohive Networks Inc HIVE:NYQ
00:10:00
Inside Look: Privacy and Cybersecurity Law with Alex Rutherford | Miguel A. Zaldivar, Jr. - Chief Executive Officer of Hogan Lovells
00:10:00
Embracing Authenticity and Leadership: Tricia Glynn's Journey in Private Equity |Tricia Glynn, Managing Director,  Advent International.
00:10:00
Navigating Inflation: Peter Kraus on Silver, Precious Metals, and Economic Challenges Ahead
00:10:00
Diversey IPO Preview with CEO Phil Wieland | Phil Wieland - CEO of Diversey Holdings
00:00:00
Discusses what is unique about the company and what newsflow investors can expect - Michel Baijot, CEO of Asit Biotech
00:10:00
Evolution of Independent Wealth Management | Brian O'Neal, President, Cahaba Wealth Management, Inc
00:10:00
Navigating Biotech Leadership: Insights, Risks, and Personal Growth from an Industry Veteran | Marc de Garidel, CEO, Abivax SA.
00:10:00
Martin Cabrera Jr.: Empowering the Latino Community Through Wealth Creation
00:10:00
Discover the Culture at Wilson Sonsini | Lori P. Westin - PARTNER of Wilson Sonsini
00:10:00
Lawrence Stroll Unveils Aston Martin's New Vanquish and Dual Market Strategy | Lawrence Stroll, Chairman, Lawrence Stroll Aston Martin Lagonda Global Holdings PLC.

© 2017 - Neuhu+